EvidenceCare

Nashville, TN · Founded 2014 · Privately Held (backing)

Developer of a clinical decision support platform intended to integrate seamlessly into a clinician's electronic health record workflow, delivering customized, interactive, and evidence-based… EvidenceCare is based in Nashville, TN and was founded in 2014. It was valued at $77.4 million at its later-stage round in Mar 2025, the last priced event on record. It has raised $56.8 million across 3 recorded rounds; the latest was a $9.6 million early-stage round in Mar 2025.

PMV mark · valuation
$77.4M
Oct 2026
Priced at
its later-stage round
Mar 2025
Total raised
$56.8M
Last round
Early Stage VC
Mar 2025
What is EvidenceCare worth?
$77.4MPrivateMarketView mark · Oct 2026

Valued at $77.4M at its later-stage round, Mar 2025. Nothing has traded since.

Free account
More of EvidenceCare with a free account
  • ·The complete investor list: 12 names
  • ·Watch EvidenceCare: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

EvidenceCare funding history

3 rounds
DateRoundRaisedPost-money
Mar 2025Early Stage VC$9.6M▮
Mar 2025Early Stage VC$15.4M▮
Apr 2020Seed Round$580K▮
Unlock post-money valuations

Membership and data by Private Market View

EvidenceCare valuation

EvidenceCare was valued at $77.4 million at its later-stage round in Mar 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has EvidenceCare raised?

EvidenceCare has raised $56.8 million in total; 3 of its rounds are on record, from 2020 on. The largest on record was a $9.6 million early-stage round in Mar 2025.

EvidenceCare has filed 4 Form Ds with the SEC since 2020, most recently in Mar 2025 ($9.6 million sold to 66 investors).

How EvidenceCare's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For EvidenceCare, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about EvidenceCare

What is EvidenceCare worth?
EvidenceCare is valued at $77.4M as of Oct 2026. Valued at $77.4M at its later-stage round, Mar 2025. Nothing has traded since.
How much has EvidenceCare raised?
EvidenceCare has raised $56.8M in total funding across 3 recorded rounds.
When did EvidenceCare last raise?
EvidenceCare last raised in Mar 2025 (Early Stage VC), raising $9.6M.